{{filterContent.facetedTitle}}

{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}

Publications

Registering maximum ex-works prices on pharmaceuticals

Following the overview of the new requirements to price setting on pharmaceuticals for treatment of oncological and cardiovascular diseases PwC Belarus team prepared a short commentary on the planned procedures for calculation of maximum ex-works prices that were recently approved by the Ministry of Antimonopoly Regulation and Trade of the Republic of Belarus (hereinafter – MART), as well as on the order of registering maximum ex-works prices of manufacturers established by the Resolution of the Council of Ministers of the Republic of Belarus dated 31 October 2018 No. 776 “On Registering Maximum Exworks Prices of Manufacturers for Pharmaceuticals”.


{{filterContent.facetedTitle}}

Follow us